Eden Research Share Discussion Threads

[supersonico] 03/12/2016 12:44

Nice Find 33...

Good to See the Daily Mail covering Fraudulent Technology don't you think Frothy

[supersonico] 23/11/2016 17:08

hxxp://www.aljazeera.com/programmes/specialseries/2016/11/circle-poison-pesticides-developing-world-161115084547144.html

Hey Frothy one for you to watch since your so interested in Fraudulent technology.

[supersonico] 13/11/2016 13:58

hxxp://www.esmmagazine.com/lidl-launches-new-free-organic-lines-italy/34552

Discounter Lidl has launched a new range of own-label free-from and organic products in Italy, just-food.com has reported. The range will include more than 60 products including frozen, fresh and dried products, as well as wine and drinks.

[supersonico] 13/11/2016 08:32

Times they are a changing.

hxxp://www.organicandhealthy.org/2016/11/aldi-goes-full-organic-bans-pesticides.html

[mandatory] 06/11/2016 12:30

Lots of Long term holders there.

I wonder what their price targets are, should various hurdles be achieved like good sales for 3aey, or a deal for our anti nematodes product.

[supersonico] 05/11/2016 07:35

quotes.wsj.com/UK/XLON/EDEN/company-people

Ownership Eden Research PLC
Mutual Funds that own EDEN
Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Artemis Alpha Trust Plc
12,152,818
6.58%
+1,758,126
0.99%
04/30/16
Baronsmead VCT 2 Plc
7,985,000
4.32%
+7,985,000
0.51%
03/31/16
Baronsmead VCT 3 Plc
8,531,215
4.62%
+8,531,215
0.63%
06/30/16
Baronsmead VCT 5 Plc
1,895,825
1.03%
+1,895,825
0.49%
06/30/16

[supersonico] 04/11/2016 17:36

Selling fast in Italia



Institutions taking stakes

hxxp://quotes.wsj.com/UK/XLON/EDEN/company-people

Product validation

hxxp://smartagro.it/3logy-mediaglia-doro-al-macfrut-innovation-award/

[supersonico] 19/10/2016 07:43

Cimpany evangelosta bigo Miiky Wilteresta has pistedo simea bullishi mitteringsa recentlyo sheepleo. Nithinga new Winderu howe the $3m dillar Piwerhouse twripentechi ire douingo. piii

[weyweyumfozo] 18/10/2016 23:38

"Winder"?

Is that written in pronunciation style Scottish?

[quazie12] 18/10/2016 23:12

Company evangelist. MW has posted some bullish mutterings recently sheeple. Nothing new. Winder how the £3m dollar powerhouse twrpenetech are doing. Pmsl

[supersonico] 02/10/2016 07:48

Sipcam Getting the word around Italia



PLUS...



PLUS;



EQUALS...

[the prophet] 01/10/2016 13:47

worth checking out Eden's recent tweets



They include

'Sipcam Italia’s “3logy” (aka Eden’s 3AEY botryticide)- nearly sold out at a major dealer near Bari, Italy last week'

and

'Eden’s 3AEY treated 300 hectares of table grapes at this producer near Bari'

It's good to hear, the recent results did say things had gone well in Italy.
Just a shame it's all so frustratingly slow, things like Portugal and France approving 3AEY are outside Eden's control, but this deal for the nematicide is taking aeons. I know the deal has to be right and that these multi-nationals don't excactly hurry themselves, all the same.....

[supersonico] 28/9/2016 13:39

You most likely right about the tough market environment.
I'm glass half full on the RNS/results. Time will tell.

[quazie12] 28/9/2016 13:21

Exactly SS a lot of words to explain away the fact the market for edens products is a tough environment and end users not as interested as BoD would have shareholders believe.

[supersonico] 28/9/2016 13:12

ShoreCap Report.

Commercial progress
The financial results for the period alone do not really highlight the progress the business has made in the first six months of FY2016F, in our view. We believe Eden has made some significant steps forward in H1 from an operational standpoint most particularly in terms of gaining the required regulatory approvals in a number of countries to enable the sales of its product 3AEY via in-country partners. Encouragingly, the period also saw the first commercial sales of 3AEY. Looking forward, we expect the second half of the year to see a continuation of the positive operational momentum reported in H1 that should also deliver more material financial benefits to the business. The heavy weighting of revenue to H2 is in part a reflection of the timing of the botrytis season in Southern Europe which typically begins in August and extends through harvest to mid to late September.

Products evaluation update
From a financial perspective, it is Eden’s’ products and technologies under commercial evaluation that are the key drivers behind our forecasts for FY2016F. In that respect, we note management’s comments that negotiations in regard to its nematicide product are continuing with a multi-national industry leader and progress has been made towards a satisfactory conclusion. A final agreement is expected this year covering multiple territories around the world subject to further negotiation.
Furthermore, a number of evaluation projects for both Eden’s technologies and products are ongoing and we note Sean Smith, CEO’s comments
“I am pleased with the progress that is generally being made as well as with regulatory progress where territories such as the USA are now being actively pursued”.
Value potential becoming increasingly visible
Overall, we believe H1 2016A has been a further period of progress for Eden with further regulatory approval and the company gaining its first commercial sales. Going forward, we expect further progress in H2 and we are hopeful that this can include some positive newsflow in relation to the group’s nematicide product. Such progress would not only be positive from a financial perspective but it would also add diversification to the group thereby further reducing its risk profile whilst adding to its commercial credibility.
With a strong balance sheet in place post the capital raising and ongoing tight cost control, the company looks well placed to accelerate its development over the coming years. Based on our assumptions Eden’s shares are trading on an EV/EBITDA ratio for FY2017F of 9.9x, which is projected to fall to a lowly 3.3x in the following year. This suggests a compelling opportunity, in our view. House Stock.

[quazie12] 28/9/2016 12:37

Pmsl £110,000 revenues in 6 months thats not even the MD's monthly wage.

[supersonico] 22/9/2016 16:08

Did someone say Fraudulent technology ??

hxxp://smartagro.it/3logy-mediaglia-doro-al-macfrut-innovation-award/

[quazie12] 18/9/2016 10:00

SS off topic again. WTF is Frothy and what was the FRC letter ? Whats this got to do with performance of Eden in the field exactly ?Q12